MedPath

CURADEL SURGICAL INNOVATIONS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery

Phase 2
Recruiting
Conditions
Injury of Ureter During Surgery (Disorder)
Interventions
Drug: Placebo Comparator
First Posted Date
2023-10-26
Last Posted Date
2025-07-14
Lead Sponsor
Curadel Surgical Innovations, Inc.
Target Recruit Count
336
Registration Number
NCT06101745
Locations
🇺🇸

Cedars Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Board of Trustees of Leland Stanford Junior University, Redwood City, California, United States

🇺🇸

University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.